CALGARY, ALBERTA--(CCNMatthews - April 9, 2007) - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced today that it will host a live teleconference/webcast with a Q&A session to follow on Wednesday, April 11, 2007 at 11:00 am MDT. The teleconference/webcast will provide securities analysts, shareholders, media and other key stakeholders the opportunity to hear from Donald McCaffrey, President and CEO, who will provide a corporate overview of the emerging dynamics of the atherosclerosis marketplace. Additionally, Mr. McCaffrey will discuss how Resverlogix's key technology, NexVasTM PR, is clearly differentiated and well positioned to address the enormous unmet medical need in this important therapeutic segment. Details of the ongoing strategic analysis with UBS Securities will not be discussed.
